Table 4. Distribution of CEA reactivity among the primary sites of metastatic adenocarcinomas.
Primary sites | CEA Positive | Total |
---|---|---|
Lung | 7 (78%) | 9 |
Colon | 7 (100%) | 7 |
Breast | 4 (57%) | 7 |
Stomach | 2 (67%) | 3 |
Ovary | 0 (0%) | 2 |
Unknown | 1 (50%) | 2 |
CEA= carcinoembryonic antigen.